Institute of Bio-Sensing Technology

IBST Launch Event


IBST is an initiative of UWE, Bristol


Latest News

» All News



» All Events



Download the Making Sense of Sensors: Markets and Technologies report


Medilink Member Logo

IBST is a member of Medilink South West, the region’s life science industry network.


IBST is a member of the Health & Life Sciences Sector Group.

Our purpose is to engage with local life sciences, health and social care organisations to explore areas that could be developed to promote the health and life sciences business sector in the West of England LEP region.

_________________________________

 

Search


Twitter

SCIENCES CONVERGE TO CREATE NEW PLATFORM TECHNOLOGIES AND WITH EVOLVING COLLABORATIVE NETWORKS, CREATE NEW PRODUCT PIPELINE MODELS TO GENERATE LEADING INNOVATION

Stanley Underwood North, III, Partner, LeClairRyan

New platform technologies are converging across the fields of healthcare and the environment.  During the past century, academic and industrial institutions ever increasingly specialized in ever narrower and narrower fields of science and technology, however this trend appears to be reversing itself as new platform technologies emerge which require the collaboration of multiple scientific disciplines from multiple regional clusters.  These new platform technologies in turn can have a broad application into many fields and industries.  This trend is presently unfolding in New Jersey, where regional collaborative networks with the South West of England are demonstrating successful results in breakthrough products and solutions for healthcare and the environment with global collaborations across multiple scientific disciplines and institutions.

These evolving initiatives are a back drop to a larger challenge facing our two respective regions.  It is suggested that our current century will be the century of the emergence of China and India as the dominating innovative forces in the world’s economy.  Undoubtedly technology is spreading to emerging markets faster than it has ever done before, however I believe that such a suggestion is premature.  Our willingness to invest in the infrastructure necessary to conduct research and development on a regional networked collaborative basis, licensing our innovations back and forth to our areas of respective strengths at ever higher levels puts us on the path of inventing new industries, new cures, and bodes well for maintaining our current lead in generating innovative ideas to make both of our regions and the world as a whole a better place to live in by 2100.

Biography: Stanley U. North, III

Mr. North is a Partner in the LeClairRyan’s Corporate Group and Chair of the International Trade and Investment Committee of the New Jersey State Bar Association. He focuses his practice on international trade and investment, securities law, corporate and commercial transactions, mergers, acquisitions and business combinations and other issues encompassing the full range of commercial transactions. He represents foreign and domestic companies, public and private, in their ongoing operations as well as in complex domestic and international business transactions including deals involving businesses in biotechnology, medical devices, high-technology, health care and environmental remediation industries, among others. Mr. North advises foreign companies in successfully establishing their presence in North America in accordance with applicable corporate, immigration, intellectual property and other regulatory requirements.  On July 4, 2007, Mr. North presented at the administrative launch of Institute of Bio-Sensing Technology by the University of the West of England proposing to collaboratively network the life science clusters of the South West of England and of the State of New Jersey and has subsequently been seeking to make such a collaboration a success.